Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%.
Marani’s M•wrap for foetal and and maternal heart signal monitoring is intended to give patients an at-home monitoring option versus travelling to a clinic.
One of the main reasons ovarian cancer is among the deadliest forms of cancer is timing: When doctors catch it early, the five-year survival rate can be more than 90%. But when doctors catch it late, in stages 3 or 4, five-year survival is less than half that.
Targeting KDM2B or downstream protein complexes it recruits may exploit a vulnerability in high-risk medulloblastoma subgroups that currently lack targeted therapies, according to a study led by St. Jude Children’s Research Hospital and Hopp Children’s Cancer Center Heidelberg (KiTZ).
In a study focused on aggressive breast and pancreatic cancers, scientists have discovered how tumors surrounded by a protective “scaffold” of dense, scar-like tissue manage to thrive—despite the scaffold severely restricting the blood supply and nutrient delivery essential for growth.
The first at-home urine test built to track stress patterns over time using a biological signal instead of a wearable estimate
Composition of matter patent secures exclusive protection for Anixa’s breast cancer vaccine in Australia through 2040, expanding the Company’s growing global IP estate
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis (“SOARA”) Clinical Validation Study following Institutional Review Board approval
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
NORCROSS, Ga., Sept. 18, 2026 /PRNewswire/ — Koning Health, a global leader in advanced breast imaging technology, today announced that the Koning Breast CT System has been successfully included in the Australian Register of Therapeutic Goods (ARTG), marking an important regulatory milestone for the company’s expansion into the Australian market.